BREAKING NEWS

Caliper and AntiCancer announce cross-licensing of intellectual property and settlement of litigation [PDF]

Kevin Hrusovsky, President and CEO of Caliper, and Robert Hoffman, Ph.D., President and CEO of AntiCancer